The Kotak Nifty Midcap 150 ETF, managed by Kotak Mahindra Asset Management Company Limited, aims to replicate the Nifty Midcap 150 Index's performance, operating as an open-ended scheme focused on market cap weighting.

Employing a tracking approach, the fund seeks to mirror the Nifty Midcap 150 Index TRI, although it acknowledges the potential for tracking errors, with a recorded tracking error of 1.33%.

The portfolio is diversified across various sectors, with a notable concentration in Pharmaceuticals and Biotechnology, comprising 7.41% of total allocations, highlighting the fund's sectoral bias and potential concentration risk.

In the past year, the fund has delivered a commendable return of 10.8%, reflecting its alignment with mid-cap market performance, while detailed long-term CAGR data remains unavailable at this time.

With a fund size of ₹4.58 Cr and a low expense ratio of 0.1%, it offers investors an efficient access point to mid-cap equities, managed by a team of experienced fund managers.